Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60M
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
35.6M
-
Shares change
-
+1.38M
-
Total reported value, excl. options
-
$353M
-
Value change
-
+$15.3M
-
Put/Call ratio
-
0.77
-
Number of buys
-
56
-
Number of sells
-
-31
-
Price
-
$9.93
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q1 2023
123 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2023.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.6M shares
of 60M outstanding shares and own 59.27% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (11.4M shares), VANGUARD GROUP INC (2.5M shares), Knoll Capital Management, LLC (2.07M shares), EAGLE ASSET MANAGEMENT INC (1.84M shares), Verition Fund Management LLC (1.57M shares), MORGAN STANLEY (1.18M shares), DIMENSIONAL FUND ADVISORS LP (1.12M shares), MILLENNIUM MANAGEMENT LLC (1.12M shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1.1M shares), and BlackRock Inc. (985K shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.